CDC Director Dr. Walensky made the right decision last night on boosters. 🧵
Boosters now available (not required) for Pfizer vaxxed after 6 months:
🔵  65 and older
🔵  healthcare workers
🔵  nursing home residents
🔵  50 and older with health problems
apnews.com/article/corona…
This was in line with the FDA decision last week. It also matches my suggestions two weeks ago on TWIV and VOSD. And earlier on UCSF Grand Rounds. It makes sense to have vaccine boosters available to these people, who received the Pfizer vaccine.
Again, the Pfizer vaccine booster shot is *available*. It is not *required* to count as fully vaxxed. That is because without the booster shot, the vaccine is still doing an outstanding job at preventing serious COVID-19.
The booster shot will prevent most *cases* of coronavirus infection (mild infections), and will probably generate more durable protection and immune memory.
Here are graphs of coronavirus infections and hospitalizations from Kaiser, with my vaccine comments above.
Pfizer vaccine efficacy against detectable infections probably wanes from ~90% to ~50% after 6 months, in the Delta era.
For people 65 and older who got the Pfizer vaccine, I think it is wise to get the 3rd dose (booster). It is a "better safe than sorry" approach, preventing cases of infection and potentially preventing hospitalizations over the next year. Balancing what we current know…
, which includes the persistent intensity of the Delta variant epidemic in America, and the coming winter season.
For healthcare workers who got the Pfizer, I think it is wise to get the 3rd dose (booster) to prevent cases and lost work time. Given that a PCR+ test results in a requirement to not go to work many places—even as an asymptomatic infection—it is helpful to get the 3rd dose…
preventing those asymptomatic and mild infections and transmissions.
Of those four groups of people, I think boosters are most highly recommended for nursing home residents, given that those have been sites of the worst outbreaks and there has been evidence of waning protection in that setting in the US.
It is quite reasonable that the FDA and the CDC did not recommend Pfizer booster shots more widely, because (1) the benefit is less clear in younger adults (and 16-17 y olds), and (2) the safety data provided to the FDA was limited. We hold vaccines up to a high safety standard.
It is appropriate to require reactogenicity (side effect) data in more than ~250 people (As I noted on UCSF Grands Rounds).
My understanding is data for over 1,000 people has been formally collected in Israel, and side effects were the same as the 2nd shot—plus over 3 million Israelis have received a 3rd shot-- so I have no safety concerns about the Pfizer 3rd dose,
but I would still want to see a larger formal data set for broader approval of a booster.
I appreciate this: "For most people, if you’re not in a group recommended for a booster, “it’s really because we think you’re well-protected,” said Dr. Matthew Daley of Kaiser Permanente Colorado."
It is plausible that the continuing protection by the Pfizer vaccine against COVID-19 hospitalizations is due to good durable T cell and B cell memory to the RNA vaccines. Discussed here
This Pfizer booster policy does NOT immediately apply to people who got Moderna or J&J vaccine. Moderna is in the process of making a similar request to the FDA and CDC in the coming weeks. And J&J is in the process of making a similar request for a 2nd shot of their vaccine.
There is some evidence that protective immunity from the Moderna vaccine is more durable than the Pfizer vaccine. It is worth considering each vaccine independently and assessing the data.
As always, the biggest problem in America is the large number of unvaccinated adults. Any dose of vaccine that can be gotten to an unvaccinated American is FAR MORE valuable than a dose of vaccine to an already vaccinated American.
There are 53 MILLION unvaccinated Americans eligible for COVID vaccines. With almost 2,000 Americans dying every day from COVID, and almost every one of them unvaccinated.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Prof. Shane Crotty

Prof. Shane Crotty Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @profshanecrotty

20 Sep
Good news! Pfizer data today indicate they have a safe and effective COVID-19 vaccine for kids ages 5 to 11. Kids vaxxed by Halloween? 🧵
🔵  Antibody titers as high as adults
🔵  "Favorable safety profile" with 10 microgram dose used
🔵  Filing with FDA

pfizer.com/news/press-rel…
🔵  Antibody titers were as high as adults

The fact that the peak antibody titers are equal between the kids 5 to 11 years old and young adults indicates the COVID vaccine will be protective in the kids.
🔵  "Favorable safety profile" with the 10 microgram dose used

Pfizer used a dose of 10 in the kids instead if the 30 used in adults. That was a reasonable decision, and they see fewer side effects with the lower kid dose (fevers, chills, etc). Other doses were tested early on.
Read 10 tweets
20 Sep
Good news! Pfizer data today indicate they have a safe and effective COVID-19 vaccine for kids ages 5 to 11. Kids vexed by Halloween? 🧵
🔵  Antibody titers as high as adults
🔵  "Favorable safety profile" with 10 microgram dose used
🔵  Filing with FDA.

pfizer.com/news/press-rel…
🔵  Antibody titers were as high as adults

The fact that the peak antibody titers are equal between the kids 5 to 11 years old and young adults indicates the COVID vaccine will be protective in the kids.
🔵  "Favorable safety profile" with the 10 microgram dose used

Pfizer used a dose of 10 in the kids instead if the 30 used in adults. That was a reasonable decision, and they see fewer side effects with the lower kid dose (fevers, chills, etc). Other doses were tested early on.
Read 10 tweets
14 Sep
Our newest study is out in Science!
It cover 5 COVID-19 RNA vaccine topics. Using samples from the "low dose" 25mcg Moderna RNA COVID-19 vaccine clinical trial 🧵👇🏼
science.org/doi/10.1126/sc…
By the LJI team! @Dani6020 @SetteLab @jmateust @ljiresearch
The five finding summarized here:
🔵  T cell memory to an RNA vaccine at 7 months
🔵  Vaccine dose sparing (25mcg v 100mcg)
🔵  Vaccine v. natural immunity
🔵  T cell memory with age
🔵  Pre-existing crossreactive memory T cells: Do they do anything?
🔵  T cell memory to an RNA vaccine:

Impressive T cell memory at 7 months (6 months after 2nd dose). CD4s & CD8s. Tfh & cytokine+.

Overall, looks like two doses of an RNA vaccine generates impressive T cell memory that is likely to last for many years.
Even 25mcg Moderna dose
Read 12 tweets
31 Aug
Just a friendly reminder that this study also addressed natural immunity compared to vaccine immunity. Vaccine immunity did somewhat better than natural immunity, including against Delta. Image
In that large, carefully done, prospective, longitudinal study in the UK of over 300,000 people with regular testing, both vaccine immunity and natural immunity showed significant protection against COVID-19, with vaccine immunity doing somewhat better than natural immunity. ImageImage
As a prospective study, with a randomization component, the conclusions have higher confidence compared to some other studies. including against Delta.
Read 4 tweets
21 Aug
Boosters+global equity:
Practically speaking, the US should continue to retain enough doses to vaccinate all unvaccinated Americans. But resistance to vaccination remains high, so there is probably little to no real cost in allowing Americans who want boosters to get a 3rd dose
The USA has to keep trying hard to vaccinate the unvaccinated. But many of those reserved doses will likely expire otherwise, sadly.

Discussed some in the chat with @CarlosdelRio7 @Bob_Wachter at the end
Any vaccine dose given to an unvaccinated American is FAR more valuable than a 3rd dose given to a vaccinated American. For preventing deaths, hospitalizations, cases, and transmissions.
washingtonpost.com/outlook/corona…
Read 7 tweets
20 Aug
I have no problem with boosters allowed at 8 months for people who want them.

Is there American data indicating waning immunity against Delta? No. Nothing substantial.

Is there uncertainty about protective efficacy against Delta COVID-19 at 6 months? Yes 🧵
The COVID vaccines are incredible--they have exceeded all expectations. But, Delta is tougher to stop. It is so transmissible. The original coronavirus wasn't that hard for the immune system to stop, and 2-doses of vaccine worked amazing.
2-dose gives overall good immune memory. New Moderna science paper on antibodies at 6 months. Our T cell data. Multiple memory B cell data. The COVID vaccines have worked incredibly well! Six month clinical trial efficacies of 91% and 93%.
Read 12 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(